Zsolt Némethy

Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist–Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

Béla Kiss, Attila Horváth, Zsolt Némethy et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 358 citations

DAXX, FLASH, and FAF-1 Modulate Mineralocorticoid and Glucocorticoid Receptor-Mediated Transcription in Hippocampal Cells—Toward a Basis for the Opposite Actions Elicited by Two Nuclear Receptors?

D. Obradović, Marilyn Tirard, Zsolt Némethy et al. · Molecular Pharmacology · 2004 · 92 citations

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15

Béla Kiss, I. Laszlovszky, Attila Horváth et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 2008 · 60 citations

Psychiatry, I. Neurochemical Characterisation, Medicine +10

<p>Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine</p>

Béla Kiss, Zsolt Némethy, Károly Fazekas et al. · Drug Design Development and Therapy · 2019 · 48 citations · Full text

SPECIFIC AMINO ACIDS MODERATE THE EFFECTS OF Ni 2+ ON THE TESTOSTERONE PRODUCTION OF MOUSE LEYDIG CELLS IN VITRO

Zsolt Forgács, Zsolt Némethy, Csaba Révész et al. · Journal of Toxicology and Environmental Health · 2001 · 26 citations